Next Science (ASX:NXS) share price swings on lowered earnings update

The Next Science share price went into a spin after a lowered earnings guidance sent investors running.

| More on:
Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Next Science Ltd (ASX: NXS) share price went from red to green before finishing back in the red during afternoon trade.

At 3pm, shares in the company were trading for $1.80 – down 1.1% – before rising to $1.87 within half an hour. Just 8 minutes later, however, the Next Science share price was even deeper in the red than before. It ended the day at $1.76 – down 3.3%.

The volatile price movement came after the technology company announced it was lowering forecasted revenue for the second half of FY21.

Let's take a closer look at today's update.

Earnings forecast drops

In a statement to the ASX, Next Science said it expected revenue for the first half of calendar year 2021 to be between $3.5 million and $4 million.

Judith Mitchell, managing director of Next Science, said of the figure:

We expect H1 2021 revenue to exceed total revenue for FY 2020 and our growth rate will be at least 230% on the prior corresponding period.

However, back in January this year, Next Science said it expected the earnings trajectory from Q2 to continue into the second half of this financial year. Earnings for that period were $2.3 million and the announcement sent the Next Science share price 8% higher that day.

Extrapolating this figure, Next Science predicted revenue for the second half of the financial year to be $4.6 million. From today's announcement, that means the current projection is 13% lower at best and 24% lower at worst.

Investors responded to the updated numbers by sending the Next Science share price seesawing.

Next Science share price snapshot

Over the past 12 months, the Next Science share price has increased 29.3%. However, it has not fully recovered since the COVID market crash of March 2020. On 5 March that year, Next Science shares were trading for $2.19. Over the previous 12 months, the highest price these same shares have traded at is $2.06.

Next Science has a market capitalisation of around $350 million.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Next Science Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

A man activates an arrow shooting up into a cloud sign on his phone, indicating share price movement in ASX tech shares
Technology Shares

With revenue soaring, should I buy Xero shares today?

Xero achieved 25% operating revenue growth in H1. Is the tech company a buy?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Earnings Results

Why is this ASX tech stock surging 24% to a record high today?

Shareholders of this tech stock will be celebrating today after it hit a record high.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Technology Shares

Why this beaten-up ASX All Ords stock just rocketed 31%

What is getting investors excited on Tuesday morning? Let's find out.

Read more »

Smiling man working on his laptop.
Technology Shares

3 reasons WiseTech shares could still be a buy

This investment could still do well over the long term.

Read more »

A corporate female wearing glasses looks intently at a virtual reality screen with shapes and lights representing Block shares going up today
Technology Shares

Is this buy-rated ASX 300 tech stock a future star?

Goldman Sachs has good things to say about this tech stock.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why is everyone talking about ResMed shares?

It’s been a good year for ResMed shareholders. Let’s find out why.

Read more »

rugby player scores touchdown
Technology Shares

Are Catapult shares still a buy after their 145% touchdown in 2024?

What do the experts think could be next?

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Technology Shares

Why today is a big day for Pro Medicus shares

Records are being broken by this share on Monday. What's going on?

Read more »